Last reviewed · How we verify
NCT05777564: THIPO
Tolerability of High Intensity Exercise for Knee Osteoarthritis
NA trial testing High intensity exercise in Knee Osteoarthritis in 41 participants. Completed in 8 February 2024.
8 February 2024
Quick facts
| Lead sponsor | Frederiksberg University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 41 |
| Start date | 28 March 2023 |
| Primary completion | 8 February 2024 |
| Estimated completion | 8 February 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- High intensity exercise
Conditions studied
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Frederiksberg University Hospital
Who can join
19 and older, any sex, with Knee Osteoarthritis or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Current knee osteoarthritis (OA) guidelines recommend knee specific exercise as treatment for knee OA pain. However, up to 87 % of patients with knee OA have at least one other chronic condition, typically cardiovascular in nature. The elevated risk of cardiovascular health problems can be mitigated by performing aerobic exercise. By consequence, it seems logical to apply aerobic exercise for this patient group as the symptomatic benefit is equal to other types of exercise. Aim: This study aims to assess the tolerability of cardiovascular exercise using High Intensity Interval Training (HIIT) on different self-selected exercise equipment in patients with knee OA and at least one CVD risk factor. Hypothesis: The hypothesis is that performing HIIT exercise is tolerable when having knee OA and at least one CVD risk factor. Method: The study is a prospective cohort study designed to assess if HIIT performed by patients with knee OA and at least one modifiable CVD risk factor influence knee pain. The investigators plan to include 40 participants. The participants will be recruited from the osteoarthritis outpatient clinic at Bispebjerg-Frederiksberg hospital. This study will include participants with a clinical diagnosis of knee OA (either one or both knees) and at least one CVD risk factor (obesity, hypertension, elevated HbA1c (long-term blood glycose), elevated triglycerides, elevated cholesterol (LDL)). All participants will attend the HIIT intervention 3 times per week, for 12 weeks. Before a participant attend their first exercise session, he/she will be asked to complete an educational session about knee OA and aerobic exercise. Participants will have a pre-screening visit (phone call), a screening visit, and a baseline visit, before the 12-week exercise period (3 sessions weekly), and after completion of the exercise period a follow-up visit. Finance: This study is fully funded by Sygesikring "Denmark". Publication: All results, both negative, positive, and inconclusive will be published. Should publication fail, the results will be made publicly available.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Tolerability of high intensity interval training (HIIT) in individuals living with knee OA and at risk for cardiovascular disease: A prospective cohort study (THIPO).
Pedersen ME, Bandholm T, Ried-Larsen M, Bartholdy C, et al · · 2026 · cited 1× · PMID 41630776 · DOI 10.1016/j.ocarto.2025.100712
Verify or expand the search:
- PubMed search for NCT05777564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High intensity exercise
Trials testing the same drug.
- NCT07375420 — Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer? · NA · recruiting
- NCT05745922 — Acute Effects of Endurance Exercise on Breast Milk Composition in Women With Overweight/Obesity · NA · completed
- NCT05768165 — High-intensity Interval Exercise in Rheumatoid Arthritis · NA · active not recruiting
- NCT03335332 — High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy · NA · completed
- NCT04806152 — Sarcopenia and Combined-modality Exercise · NA · terminated
Other recruiting trials for Knee Osteoarthritis
Currently open trials in the same condition.
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
- NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
Other Frederiksberg University Hospital trials
Trials by the same sponsor.
- NCT06170229 — Aerobic Vs Neuromuscular Exercise for Knee OA · NA · recruiting
- NCT05898867 — Cognitive Bias and Heuristics in Patients With Knee Osteoarthritis · completed
- NCT05225480 — Reinforcement of Placebo Response in Knee Osteoarthritis: A Randomised Trial · NA · completed
- NCT04090918 — Novel Methods for Characterizing Patients With Post-operative Atrial Fibrillation Secondary to Abdominal Surgery · withdrawn
- NCT04739839 — Risk Factors for Low Back Pain in Adults a 23-year Prospective Cohort Study of 14-15-year-old Schoolchildren. · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05777564 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Frederiksberg University Hospital
- Last refreshed: 29 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05777564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing